Search Results - "Moody, M Anthony"

Influenza and Antibody-Dependent Cellular Cytotoxicity by Von Holle, Tarra A., Moody, M. Anthony

“…Despite the availability of yearly vaccinations, influenza continues to cause seasonal, and pandemic rises in illness and death. An error prone replication…”
Get full text

A rhesus macaque model of Asian-lineage Zika virus infection by Dudley, Dawn M., Aliota, Matthew T., Mohr, Emma L., Weiler, Andrea M., Lehrer-Brey, Gabrielle, Weisgrau, Kim L., Mohns, Mariel S., Breitbach, Meghan E., Rasheed, Mustafa N., Newman, Christina M., Gellerup, Dane D., Moncla, Louise H., Post, Jennifer, Schultz-Darken, Nancy, Schotzko, Michele L., Hayes, Jennifer M., Eudailey, Josh A., Moody, M. Anthony, Permar, Sallie R., O’Connor, Shelby L., Rakasz, Eva G., Simmons, Heather A., Capuano, Saverio, Golos, Thaddeus G., Osorio, Jorge E., Friedrich, Thomas C., O’Connor, David H.

“…Infection with Asian-lineage Zika virus (ZIKV) has been associated with Guillain–Barré syndrome and fetal abnormalities, but the underlying mechanisms remain…”
Get full text

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies by Li, Dapeng, Edwards, Robert J, Manne, Kartik, Martinez, David R, Schäfer, Alexandra, Alam, S Munir, Wiehe, Kevin, Lu, Xiaozhi, Parks, Robert, Sutherland, Laura L, Oguin, 3rd, Thomas H, McDanal, Charlene, Perez, Lautaro G, Mansouri, Katayoun, Gobeil, Sophie M C, Janowska, Katarzyna, Stalls, Victoria, Kopp, Megan, Cai, Fangping, Lee, Esther, Foulger, Andrew, Hernandez, Giovanna E, Sanzone, Aja, Tilahun, Kedamawit, Jiang, Chuancang, Tse, Longping V, Bock, Kevin W, Minai, Mahnaz, Nagata, Bianca M, Cronin, Kenneth, Gee-Lai, Victoria, Deyton, Margaret, Barr, Maggie, Von Holle, Tarra, Macintyre, Andrew N, Stover, Erica, Feldman, Jared, Hauser, Blake M, Caradonna, Timothy M, Scobey, Trevor D, Rountree, Wes, Wang, Yunfei, Moody, M Anthony, Cain, Derek W, DeMarco, C Todd, Denny, Thomas N, Woods, Christopher W, Petzold, Elizabeth W, Schmidt, Aaron G, Teng, I-Ting, Zhou, Tongqing, Kwong, Peter D, Mascola, John R, Graham, Barney S, Moore, Ian N, Seder, Robert, Andersen, Hanne, Lewis, Mark G, Montefiori, David C, Sempowski, Gregory D, Baric, Ralph S, Acharya, Priyamvada, Haynes, Barton F, Saunders, Kevin O

“…SARS-CoV-2-neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding SARS-CoV-2 antibodies is whether they mediate disease enhancement…”
Get more information

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses by Pardi, Norbert, Hogan, Michael J, Naradikian, Martin S, Parkhouse, Kaela, Cain, Derek W, Jones, Letitia, Moody, M Anthony, Verkerke, Hans P, Myles, Arpita, Willis, Elinor, LaBranche, Celia C, Montefiori, David C, Lobby, Jenna L, Saunders, Kevin O, Liao, Hua-Xin, Korber, Bette T, Sutherland, Laura L, Scearce, Richard M, Hraber, Peter T, Tombácz, István, Muramatsu, Hiromi, Ni, Houping, Balikov, Daniel A, Li, Charles, Mui, Barbara L, Tam, Ying K, Krammer, Florian, Karikó, Katalin, Polacino, Patricia, Eisenlohr, Laurence C, Madden, Thomas D, Hope, Michael J, Lewis, Mark G, Lee, Kelly K, Hu, Shiu-Lok, Hensley, Scott E, Cancro, Michael P, Haynes, Barton F, Weissman, Drew

“…T follicular helper (Tfh) cells are required to develop germinal center (GC) responses and drive immunoglobulin class switch, affinity maturation, and…”
Get more information

Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody by Raymond, Donald D, Bajic, Goran, Ferdman, Jack, Suphaphiphat, Pirada, Settembre, Ethan C, Moody, M Anthony, Schmidt, Aaron G, Harrison, Stephen C

“…Circulating influenza viruses evade neutralization in their human hosts by acquiring escape mutations at epitopes of prevalent antibodies. A goal for…”
Get more information

Viral receptor-binding site antibodies with diverse germline origins by Schmidt, Aaron G, Therkelsen, Matthew D, Stewart, Shaun, Kepler, Thomas B, Liao, Hua-Xin, Moody, M Anthony, Haynes, Barton F, Harrison, Stephen C

“…Vaccines for rapidly evolving pathogens will confer lasting immunity if they elicit antibodies recognizing conserved epitopes, such as a receptor-binding site…”
Get more information

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors by Bonsignori, Mattia, Hwang, Kwan-Ki, Chen, Xi, Tsao, Chun-Yen, Morris, Lynn, Gray, Elin, Marshall, Dawn J, Crump, John A, Kapiga, Saidi H, Sam, Noel E, Sinangil, Faruk, Pancera, Marie, Yongping, Yang, Zhang, Baoshan, Zhu, Jiang, Kwong, Peter D, O'Dell, Sijy, Mascola, John R, Wu, Lan, Nabel, Gary J, Phogat, Sanjay, Seaman, Michael S, Whitesides, John F, Moody, M Anthony, Kelsoe, Garnett, Yang, Xinzhen, Sodroski, Joseph, Shaw, George M, Montefiori, David C, Kepler, Thomas B, Tomaras, Georgia D, Alam, S Munir, Liao, Hua-Xin, Haynes, Barton F

“…V2/V3 conformational epitope antibodies that broadly neutralize HIV-1 (PG9 and PG16) have been recently described. Since an elicitation of previously known…”
Get more information

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies by Williams, Wilton B, Meyerhoff, R Ryan, Edwards, R J, Li, Hui, Manne, Kartik, Nicely, Nathan I, Henderson, Rory, Zhou, Ye, Janowska, Katarzyna, Mansouri, Katayoun, Gobeil, Sophie, Evangelous, Tyler, Hora, Bhavna, Berry, Madison, Abuahmad, A Yousef, Sprenz, Jordan, Deyton, Margaret, Stalls, Victoria, Kopp, Megan, Hsu, Allen L, Borgnia, Mario J, Stewart-Jones, Guillaume B E, Lee, Matthew S, Bronkema, Naomi, Moody, M Anthony, Wiehe, Kevin, Bradley, Todd, Alam, S Munir, Parks, Robert J, Foulger, Andrew, Oguin, Thomas, Sempowski, Gregory D, Bonsignori, Mattia, LaBranche, Celia C, Montefiori, David C, Seaman, Michael, Santra, Sampa, Perfect, John, Francica, Joseph R, Lynn, Geoffrey M, Aussedat, Baptiste, Walkowicz, William E, Laga, Richard, Kelsoe, Garnett, Saunders, Kevin O, Fera, Daniela, Kwong, Peter D, Seder, Robert A, Bartesaghi, Alberto, Shaw, George M, Acharya, Priyamvada, Haynes, Barton F

“…Natural antibodies (Abs) can target host glycans on the surface of pathogens. We studied the evolution of glycan-reactive B cells of rhesus macaques and humans…”
Get more information

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG by Tomaras, Georgia D, Ferrari, Guido, Shen, Xiaoying, Alam, S Munir, Liao, Hua-Xin, Pollara, Justin, Bonsignori, Mattia, Moody, M Anthony, Fong, Youyi, Chen, Xi, Poling, Brigid, Nicholson, Cindo O, Zhang, Ruijun, Lu, Xiaozhi, Parks, Robert, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Rerks-Ngarm, Supachai, Gilbert, Peter B, Kim, Jerome H, Michael, Nelson L, Montefiori, David C, Haynes, Barton F

“…Analysis of correlates of risk of infection in the RV144 HIV-1 vaccine efficacy trial demonstrated that plasma IgG against the HIV-1 envelope (Env) variable…”
Get more information

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth by Roskin, Krishna M., Jackson, Katherine J. L., Lee, Ji-Yeun, Hoh, Ramona A., Joshi, Shilpa A., Hwang, Kwan-Ki, Bonsignori, Mattia, Pedroza-Pacheco, Isabela, Liao, Hua-Xin, Moody, M. Anthony, Fire, Andrew Z., Borrow, Persephone, Haynes, Barton F., Boyd, Scott D.

“…A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual…”
Get full text

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin by Whittle, James R R, Zhang, Ruijun, Khurana, Surender, King, Lisa R, Manischewitz, Jody, Golding, Hana, Dormitzer, Philip R, Haynes, Barton F, Walter, Emmanuel B, Moody, M Anthony, Kepler, Thomas B, Liao, Hua-Xin, Harrison, Stephen C

“…Seasonal antigenic drift of circulating influenza virus leads to a requirement for frequent changes in vaccine composition, because exposure or vaccination…”
Get more information

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge by Bradley, Todd, Pollara, Justin, Santra, Sampa, Vandergrift, Nathan, Pittala, Srivamshi, Bailey-Kellogg, Chris, Shen, Xiaoying, Parks, Robert, Goodman, Derrick, Eaton, Amanda, Balachandran, Harikrishnan, Mach, Linh V., Saunders, Kevin O., Weiner, Joshua A., Scearce, Richard, Sutherland, Laura L., Phogat, Sanjay, Tartaglia, Jim, Reed, Steven G., Hu, Shiu-Lok, Theis, James F., Pinter, Abraham, Montefiori, David C., Kepler, Thomas B., Peachman, Kristina K., Rao, Mangala, Michael, Nelson L., Suscovich, Todd J., Alter, Galit, Ackerman, Margaret E., Moody, M. Anthony, Liao, Hua-Xin, Tomaras, Georgia, Ferrari, Guido, Korber, Bette T., Haynes, Barton F.

“…The RV144 Thai trial HIV-1 vaccine of recombinant poxvirus (ALVAC) and recombinant HIV-1 gp120 subtype B/subtype E (B/E) proteins demonstrated 31% vaccine…”
Get full text

Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia by Salazar, Juan C., Vargas-Cely, Fabio, García-Luna, Jonny A., Ramirez, Lady G., Bettin, Everton B., Romero-Rosas, Nelson, Amórtegui, María F., Silva, Sebastián, Oviedo, Oscar, Vigil, Julie, La Vake, Carson J., Galindo, Ximena, Ramirez, Jose D., Martínez-Valencia, Alvaro J., Caimano, Melissa J., Hennelly, Christopher M., Aghakhanian, Farhang, Moody, M. Anthony, Seña, Arlene C., Parr, Jonathan B., Hawley, Kelly L., López-Medina, Eduardo, Radolf, Justin D.

“…Venereal syphilis, caused by the spirochete Treponema pallidum subsp. pallidum (TPA), is surging worldwide, underscoring the need for a vaccine with global…”
Get full text

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies by Gao, Feng, Bonsignori, Mattia, Liao, Hua-Xin, Kumar, Amit, Xia, Shi-Mao, Lu, Xiaozhi, Cai, Fangping, Hwang, Kwan-Ki, Song, Hongshuo, Zhou, Tongqing, Lynch, Rebecca M, Alam, S Munir, Moody, M Anthony, Ferrari, Guido, Berrong, Mark, Kelsoe, Garnett, Shaw, George M, Hahn, Beatrice H, Montefiori, David C, Kamanga, Gift, Cohen, Myron S, Hraber, Peter, Kwong, Peter D, Korber, Bette T, Mascola, John R, Kepler, Thomas B, Haynes, Barton F

“…Development of strategies for induction of HIV-1 broadly neutralizing antibodies (bnAbs) by vaccines is a priority. Determining the steps of bnAb induction in…”
Get more information

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies by Bonsignori, Mattia, Kreider, Edward F, Fera, Daniela, Meyerhoff, R Ryan, Bradley, Todd, Wiehe, Kevin, Alam, S Munir, Aussedat, Baptiste, Walkowicz, William E, Hwang, Kwan-Ki, Saunders, Kevin O, Zhang, Ruijun, Gladden, Morgan A, Monroe, Anthony, Kumar, Amit, Xia, Shi-Mao, Cooper, Melissa, Louder, Mark K, McKee, Krisha, Bailer, Robert T, Pier, Brendan W, Jette, Claudia A, Kelsoe, Garnett, Williams, Wilton B, Morris, Lynn, Kappes, John, Wagh, Kshitij, Kamanga, Gift, Cohen, Myron S, Hraber, Peter T, Montefiori, David C, Trama, Ashley, Liao, Hua-Xin, Kepler, Thomas B, Moody, M Anthony, Gao, Feng, Danishefsky, Samuel J, Mascola, John R, Shaw, George M, Hahn, Beatrice H, Harrison, Stephen C, Korber, Bette T, Haynes, Barton F

“…A preventive HIV-1 vaccine should induce HIV-1-specific broadly neutralizing antibodies (bnAbs). However, bnAbs generally require high levels of somatic…”
Get more information

A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection by Thomas, Rasmi, Thio, Chloe L, Apps, Richard, Qi, Ying, Gao, Xiaojiang, Marti, Darlene, Stein, Judy L, Soderberg, Kelly A, Moody, M Anthony, Goedert, James J, Kirk, Gregory D, Hoots, W Keith, Wolinsky, Steven, Carrington, Mary

“…Variants near the HLA-DP gene show the strongest genome-wide association with chronic hepatitis B virus (HBV) infection and HBV recovery/persistence in Asians…”
Get more information

Innovations in HIV-1 Vaccine Design by Jones, Letitia D., Moody, M. Anthony, Thompson, Amelia B.

“…The field of HIV-1 vaccinology has evolved during the last 30 years from the first viral vector HIV gene insert constructs to vaccination regimens using a…”
Get full text

Transient inhibition of lysosomal functions potentiates nucleic acid vaccines by Wang, Chunxi, Karlsson, Amelia, Oguin, 3rd, Thomas H, Macintyre, Andrew N, Sempowski, Gregory D, McCarthy, Kevin R, Wang, Yifei, Moody, M Anthony, Yuan, Fan

“…Nucleic acid vaccines have shown promising results in the clinic against infectious diseases and cancers. To robustly improve the vaccine efficacy and safety,…”
Get more information

Influence of HLA-C expression level on HIV control by Apps, Richard, Qi, Ying, Carlson, Jonathan M, Chen, Haoyan, Gao, Xiaojiang, Thomas, Rasmi, Yuki, Yuko, Del Prete, Greg Q, Goulder, Philip, Brumme, Zabrina L, Brumme, Chanson J, John, Mina, Mallal, Simon, Nelson, George, Bosch, Ronald, Heckerman, David, Stein, Judy L, Soderberg, Kelly A, Moody, M Anthony, Denny, Thomas N, Zeng, Xue, Fang, Jingyuan, Moffett, Ashley, Lifson, Jeffrey D, Goedert, James J, Buchbinder, Susan, Kirk, Gregory D, Fellay, Jacques, McLaren, Paul, Deeks, Steven G, Pereyra, Florencia, Walker, Bruce, Michael, Nelson L, Weintrob, Amy, Wolinsky, Steven, Liao, Wilson, Carrington, Mary

“…A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant genome-wide effect on HIV control in European Americans and is also…”
Get more information

Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2 by Liao, Hua-Xin, Bonsignori, Mattia, Alam, S Munir, McLellan, Jason S, Tomaras, Georgia D, Moody, M Anthony, Kozink, Daniel M, Hwang, Kwan-Ki, Chen, Xi, Tsao, Chun-Yen, Liu, Pinghuang, Lu, Xiaozhi, Parks, Robert J, Montefiori, David C, Ferrari, Guido, Pollara, Justin, Rao, Mangala, Peachman, Kristina K, Santra, Sampa, Letvin, Norman L, Karasavvas, Nicos, Yang, Zhi-Yong, Dai, Kaifan, Pancera, Marie, Gorman, Jason, Wiehe, Kevin, Nicely, Nathan I, Rerks-Ngarm, Supachai, Nitayaphan, Sorachai, Kaewkungwal, Jaranit, Pitisuttithum, Punnee, Tartaglia, James, Sinangil, Faruk, Kim, Jerome H, Michael, Nelson L, Kepler, Thomas B, Kwong, Peter D, Mascola, John R, Nabel, Gary J, Pinter, Abraham, Zolla-Pazner, Susan, Haynes, Barton F

“…The RV144 HIV-1 trial of the canary pox vector (ALVAC-HIV) plus the gp120 AIDSVAX B/E vaccine demonstrated an estimated efficacy of 31%, which correlated…”
Get more information